Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
29,847,520
-
Shares change
-
+611,582
-
Total reported value, excl. options
-
$173,782,820
-
Value change
-
+$3,188,518
-
Number of buys
-
32
-
Number of sells
-
-19
-
Price
-
$5.82
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q1 2020
67 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q1 2020.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,847,520 shares
of 160,529,963 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include FMR LLC (5,243,071 shares), Svennilson Peter (3,102,934 shares), Versant Venture Management, LLC (3,102,929 shares), Redmile Group, LLC (3,068,194 shares), Blackstone Group Inc (2,567,445 shares), Casdin Capital, LLC (2,270,000 shares), BlackRock Inc. (2,179,680 shares), FRAZIER MANAGEMENT LLC (2,061,758 shares), VANGUARD GROUP INC (1,038,185 shares), and Alphabet Inc. (929,022 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.